Australia markets close in 2 hours 10 minutes

Global Bioenergies SA (ALGBE.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
1.9460+0.0400 (+2.10%)
At close: 05:24PM CEST
Full screen
Previous close1.9060
Open1.9080
BidN/A x N/A
AskN/A x N/A
Day's range1.9020 - 2.0000
52-week range1.7020 - 4.3700
Volume28,803
Avg. volume19,072
Market cap35.206M
Beta (5Y monthly)1.45
PE ratio (TTM)N/A
EPS (TTM)-0.6500
Earnings date06 Mar 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est3.50
  • GlobeNewswire

    Global Bioenergies ISO 9001 certified

    PRESS RELEASE Global Bioenergies ISO 9001 certified Evry, 16 April 2024 – 05:45 p.m.: Global Bioenergies (FR0011052257 – ALGBE), a player in industrial biotechnology, announces its ISO 9001:2015 certification, the benchmark for quality worldwide. This certification is the result of 3 years of efforts led by the Company in the implementation of its production and marketing activities. Its main objectives are to ensure the quality of products sold and customer satisfaction, in order to respond ful

  • GlobeNewswire

    Global Bioenergies has received letters of intent for its plant project corresponding to forecasted annual sales of over €70 million

    PRESS RELEASE Global Bioenergies has received letters of intent for itsplant project corresponding to forecasted annual salesof over €70 million The plant will focus on high added-value cosmetics markets, with annual production capacity rescaled to 2,500 tons The total volume of letters of intent exceeds the plant's production capacityThe plant will also enable to initiate the sustainable aviation fuels market CAPEX and plant design specifications clarified Evry, 08 April 2024 – 5:45 pm CEST: Gl

  • GlobeNewswire

    Global Bioenergies: strong reduction of the loss in 2023 thanks to a significant increase in commercial activity

    PRESS RELEASE Global Bioenergies: strong reduction of the loss in 2023 thanks to a significant increase in commercial activity Sales exceeding €3M for the first timeConsolidated net loss significantly improved to -€8.7M compared to -€12M in 2022Gross cash position of €11.7M at 31 December 2023 compared to €8.8M the previous yearSuccessful commercialization of the first tons of Isonaturane™ 12 to several customers including L'OréalASTM certification received for the production of sustainable avia